TVTX's Upcoming Sparsentan PDUFA and Exciting Kidney Readouts!
Summary: The TVTX PDUFA for Sparsentan is coming up on February 17 for IgA Nephropathy (IgAN) The market reacted positively when Phase 3...
${alertText}
Want unlimited access? Try Pro free for 7 days.
TVTX's Upcoming Sparsentan PDUFA and Exciting Kidney Readouts!
Weekly Biotech Catalyst Watchlist Jan - Feb '22
Biopharma Pulse - 1/23-1/27 Weekly Review
ASCO-GU 2023 Coming Soon!
Big/Suspected Movers FAQ/User Guide
Quarterly Big Mover Biotech Stocks To Watch
Q2 2023 Product Revenue Analyses
BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis
SYFOVRE (APLS) vs. IZERVAY (Astellas)
BIIB & SAGE: Zuranolone
Apellis Pharmaceuticals (APLS)
Our platform helps you uncover your next biotech investment opportunity